Live
- Delhi police orders checking of hotels to nab criminals
- Kavya seeks people’s support for development of district
- Leaders remember People’s poet Kaloji
- BJP’s win shows people back corruption-free govt: Dattatreya
- UP: SC’s demolition verdict will help curb organised crime
- Won’t back off from ‘Pharma Village’, says Telangana CM’s brother
- SC order will stop govts from arbitrary house razing: Cong
- AP assembly session: Govt. to introduce five bills today in house Dy. Speaker election at noon
- Reject BJP’s divisive politics in Maha: Uttam
- Travan Core Devasthanam Issues Guidelines for Ayyappa Devotees Visiting Sabari
Dr Reddy's Laboratories launches cholesterol lowering drug in US
Dr Reddy\'s Laboratories today said it has launched generic Ezetimibe and Simvastatin tablets, used for reducing cholesterol, in the US market.
Dr Reddys Laboratories today said it has launched generic Ezetimibe and Simvastatin tablets, used for reducing cholesterol, in the US market.
The company has launched Ezetimibe and Simvastatin tablets in the strengths of 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg in the US market, Dr Reddys Laboratories said in a BSE filing.
The product is a generic version of MSD International GmbHs Vytorin tablets, it added.
"Dr Reddys is among the first companies to launch the generic product in the US," the company said.
According to IMS Health, Vytorin brand had the US sales of approximately USD 678 million MAT for the most recent 12 months ended February 2017, it added.
Shares of the company were trading 0.44 per cent down at Rs 2,599.50 on BSE.
